Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2015-01-23 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
GRANT OF SHARE OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the grant of share options by the company Uni-Bio Science Group Limited. It specifies details such as the number of options granted, exercise price, vesting period, and confirms that none of the grantees are directors or substantial shareholders. The document is relatively short (2719 characters) and is a formal announcement pursuant to listing rules. It does not contain financial statements, management discussion, or detailed financial data. It is not a report but an announcement about a capital-related event (share options granted). This fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes such as share options granted.
2015-01-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2014
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 December 2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. Therefore, it fits best under 'Capital/Financing Update' (CAP). The document length is substantial and contains detailed data, not just an announcement or certification, so it is not RPA or RNS.
2015-01-05 English
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 28 November 2014 from Uni-Bio Science Group Limited informing non-registered shareholders that the 2014 interim report is published on the company's website. It includes instructions on how to request a printed copy of the interim report and future corporate communications. The document does not contain the interim report itself or any substantive financial data, but rather serves as a notice of publication and availability of the report. The document length is 4569 characters, which is relatively short and consistent with a notification rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Interim Report (IR).
2014-12-01 English
Interim Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2014' and contains detailed financial statements such as the condensed consolidated statement of comprehensive income, statement of financial position, statement of cash flows, and statement of changes in equity for the six months ended 30 September 2014. It also includes notes to the condensed accounts, segment information, and other financial disclosures. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of unaudited financial data for a six-month period and reference to HKAS 34 'Interim Financial Reporting' confirms this is a comprehensive interim or quarterly financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2014
2014-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2014
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 November 2014. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's share capital structure and related securities movements. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting share capital movements to the Hong Kong Exchanges and Clearing Limited. This type of document fits the category of Share Issue/Capital Change (SHA), as it reports on share capital changes and related securities movements.
2014-12-01 English
ANNOUNCEMENT - CHANGE OF FINANCIAL YEAR END DATE
Regulatory Filings Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding a change in the company's financial year end date. It references compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and details the new financial year end date and subsequent reporting deadlines. The document is relatively short (3430 characters) and serves as an official announcement rather than a full financial report or detailed analysis. It does not contain financial statements or substantive financial data but informs shareholders and the market about a change in reporting periods. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2014-11-26 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.